Home » Clinical Trials » Solid tumors » NCT06782425
NCT06782425

A Single-center, Single-arm, Dose-escalation Exploratory Clinical Trial of the Safety, Efficacy, and Pharmacokinetics of XKDCT225 (Targeting Claudin18.2-CAR-T) Cell Injectionin Claudin18.2-positive Advanced Solid Tumors

Study Summary

A single-center, single-arm, dose-escalation exploratory clinical trial of the safety, efficacy, and pharmacokinetics of XKDCT225 cell injection in Claudin18.2-positive advanced solid tumors

Want to learn more about this trial?

Request More Info

Interventions

XKDCT225DRUG
Autologous targeted claudin18.2 chimeric antigen receptor T cell injection

Study Locations

FacilityCityStateCountry
AnYang Tumor HospitalAnyangHenanChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026